- Education, Training & Outreach
- Patients & Caregivers
- For Investigators
- Dementia in the News
- Media Room
Science Daily (May 17, 2010): Caffeine May Slow Alzheimer's Disease and Other Dementias, Restore Cognitive Function, According to New Evidence
Although caffeine is the most widely consumed psychoactive drug worldwide, its potential benefit for maintenance of proper brain functioning has only recently begun to be adequately appreciated. Substantial evidence from epidemiological studies and fundamental research in animal models suggests that caffeine may be protective against the cognitive decline seen in dementia and Alzheimer's disease (AD).
A special supplement to the Journal of Alzheimer's Disease, "Therapeutic Opportunities for Caffeine in Alzheimer's Disease and Other Neurodegenerative Diseases," sheds new light on this topic and presents key findings.
Guest editors Alexandre de Mendonca, Institute of Molecular Medicine and Faculty of Medicine, University of Lisbon, Portugal, and Rodrigo A. Cunha, Center for Neuroscience and Cell Biology of Coimbra and Faculty of Medicine, University of Coimbra, Portugal, have assembled a group of international experts to explore the effects of caffeine on the brain. The resulting collection of original studies conveys multiple perspectives on topics ranging from molecular targets of caffeine, neuropsychological modifications and adaptations, to the potential mechanims underlying the behavioral and neuroprotecitve actions of caffeine in distinct brain pathologies.